Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer

被引:27
作者
Chen, SW
Liang, JA
Yeh, LS
Yang, SN
Shiau, AC
Lin, FJ
机构
[1] China Med Univ, Sch Med, Dept Radiat Therapy, Taichung, Taiwan
[2] China Med Univ, Sch Med, Dept Oncol, Taichung, Taiwan
[3] China Med Univ, Sch Med, Dept Obstet & Gynecol, Taichung, Taiwan
[4] Natl Taiwan Univ, Sch Med, Taipei, Taiwan
[5] Shin Kong Mem Hosp, Dept Radiat Therapy & Oncol, Taipei, Taiwan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2004年 / 60卷 / 02期
关键词
cervical cancer; brachytherapy; late sequelae; radiation dose;
D O I
10.1016/j.ijrobp.2004.05.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study aimed to correlate and compare the predictive values of rectal and bladder reference doses of uniform external beam radiotherapy without shielding and high-dose-rate intracavitary brachytherapy (HDRICB) with late sequelae in patients with uterine cervical cancer. Methods and Materials: Between September 1992 and December 1998, 154 patients who survived more than 12 months after treatment were studied. Initially, they were treated with 10-MV X-rays (44 to 45 Gy/22 to 25 fractions over 4 to 5 weeks) to the whole pelvis, after which HDRICB was performed using Ir-192 remote afterloading at 1-week intervals for 4 weeks. The standard prescribed dose for each HDRICB was 6.0 Gy to point A. Patient- and treatment-related-factors were evaluated for late rectal complications using logistic regression modeling. Results: The probability of rectal complications showed better correlation of dose-response with increasing total ICRU (International Committee on Radiotherapy Units and Measurements) rectal dose. Multivariate logistic regression demonstrated a high risk of late rectal sequelae in patients who developed rectal complications (p = 0.0001;relative risk, 15.06;95% CI, 2.89-43.7) and total ICRU rectal dose greater than 16 Gy (p = 0.02;relative risk, 2.07;95% CI, 1.13-4.55). The high risk factors for bladder complications were seen in patients who developed rectal complications (p = 0.0001;relative risk, 15.2;95% CI, 2.81similar to44.9) and total ICRU bladder dose greater than 24 Gy (p = 0.02;relative risk, 8.93;95% CI, 1.79similar to33.1). Conclusion: This study demonstrated the predictive value of ICRU rectal and bladder reference dosing in HDRICB for patients receiving uniform external beam radiation therapy without central shielding. Patients who had a total ICRU rectal dose greater than 16 Gy, or a total ICRU bladder dose over 24 Gy, were at risk of late sequelae. (C) 2004 Elsevier Inc.
引用
收藏
页码:663 / 671
页数:9
相关论文
共 31 条
  • [1] HIGH-DOSE-RATE INTRACAVITARY IRRADIATION IN THE TREATMENT OF CARCINOMA OF THE UTERINE CERVIX - EARLY EXPERIENCE WITH 84 PATIENTS
    AKINE, Y
    ARIMOTO, H
    OGINO, T
    KAJIURA, Y
    TSUKIYAMA, I
    EGAWA, S
    YAMADA, T
    TANEMURA, K
    TSUNEMATSU, R
    OHMI, K
    SONODA, T
    KASAMATSU, T
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (05): : 893 - 898
  • [2] HIGH-DOSE-RATE AFTERLOADING TECHNIQUE IN THE RADIATION TREATMENT OF UTERINE CERVICAL-CANCER - 399 CASES AND 9 YEARS EXPERIENCE IN TAIWAN
    CHEN, MS
    LIN, FJ
    HONG, CH
    TU, CP
    LAN, JH
    TANG, SG
    LEUNG, WM
    WANG, TR
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (05): : 915 - 919
  • [3] The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy
    Chen, SW
    Liang, JA
    Yang, SN
    Liu, RT
    Lin, FJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04): : 955 - 961
  • [4] Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy
    Cheng, JCH
    Peng, LC
    Chen, YH
    Huang, DYC
    Wu, JK
    Jian, JJM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (04): : 1010 - 1018
  • [5] RECTAL COMPLICATIONS IN PATIENTS WITH CARCINOMA OF THE CERVIX TREATED WITH CONCOMITANT CISPLATIN AND EXTERNAL-BEAM IRRADIATION WITH HIGH-DOSE-RATE BRACHYTHERAPY - A DOSIMETRIC ANALYSIS
    CLARK, BG
    SOUHAMI, L
    ROMAN, TN
    EVANS, MDC
    PLA, C
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (05): : 1243 - 1250
  • [6] The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix
    Clark, BG
    Souhami, L
    Roman, TN
    Chappell, R
    Evans, MDC
    Fowler, JF
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (05): : 989 - 993
  • [7] TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC)
    COX, JD
    STETZ, J
    PAJAK, TF
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05): : 1341 - 1346
  • [8] DOSE-VOLUME ANALYSIS AND THE PREVENTION OF RADIATION SEQUELAE IN CERVICAL-CANCER
    CROOK, JM
    ESCHE, BA
    CHAPLAIN, G
    ISTURIZ, J
    SENTENAC, I
    HORIOT, JC
    [J]. RADIOTHERAPY AND ONCOLOGY, 1987, 8 (04) : 321 - 332
  • [9] HIGH-DOSE-RATE BRACHYTHERAPY FOR CARCINOMA OF THE CERVIX - HIGH TECH OR HIGH-RISK
    EIFEL, PJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 24 (02): : 383 - 386
  • [10] Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: Patterns of care study
    Eifel, PJ
    Moughan, J
    Owen, J
    Katz, A
    Mahon, I
    Hanks, GE
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (02): : 351 - 358